Peripheral Intravenous Catheters (PIVC) Market Size, Share & Trends Analysis Report By Product (Short Peripheral IV Catheters, Peripheral Midline IV Catheters), By Technology (Conventional Peripheral IV Catheters, Safety Peripheral IV Catheters), By End-User (Hospitals, Ambulatory Surgical Centers, Homecare, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Peripheral Intravenous Catheters (PIVC) Market Size & Growth Analysis

The global peripheral intravenous catheters market size was valued at USD 6.19 billion in 2025 and is projected to grow from USD 6.58 billion in 2026 to USD 10.66 billion by 2034, registering a CAGR of 6.23% during the forecast period from 2026 to 2034. North America dominated the peripheral intravenous catheters market with a market share of 38.6% in 2025.

Market Segmentation

Product Insights

The global market is bifurcated into short peripheral IV catheters and peripheral midline IV catheters. The short peripheral IV catheters segment dominates the market and is projected to exhibit a CAGR of 0.21% over the forecast period. Short peripheral IV catheters are used in patients who cannot absorb medication orally due to illness. Peripheral vascular access devices are widely used in inpatient and outpatient settings. Such devices are a critical component in healthcare areas. In addition, peripheral catheters are appropriate venous access devices for short-term therapies, generally less than seven days. Some frequently prescribed products for infusions by peripheral catheters include hydration, diuretics, steroids, gamma globulin, and antibiotics. These devices are tailored to provide safe and reliable care in different types, sizes, and duration.

Midline IV catheters are made of silicone or polyurethane and are available as a single or double lumen. Midline PIVCs provide better hemodilution and a longer dwelling time than short PIVCs. These catheters are generally used for venous access for 1-4 weeks and 6-10 days in neonates. Midline PIVCs can be used in inpatient and outpatient settings. Hydration, blood products, pain medications, diuretics, and some antibiotics are typical midline therapies. Therapies unsuitable for these catheters include parenteral nutrition, continuous vesicant therapy, and infusate with over 900 mOsm/L osmolality. Midline catheters are appropriate for delivering near-isotonic or isotonic solutions and solutions with a pH of 5-9.

Request Customizationto receive a tailored report.

Technology Insights

The global market is divided into conventional peripheral intravenous catheters and safety peripheral intravenous catheters. The conventional peripheral intravenous catheters segment is responsible for the largest peripheral intravenous catheters market share and is anticipated to exhibit a CAGR of 0.73% over the forecast period. Conventional PIVCs are simple, inexpensive IV lines used for short-term intravenous therapy. These PIVCs allow the safe infusion of medications, hydration fluids, blood products, and nutritional supplements. These devices help to provide treatments that cannot be administered or are less effective when given by alternative routes. Some drugs are better or more effective on intravenously owing to the drugs' rapid onset or increased bioavailability. Such therapies have increased the demand for conventional PIVCs.

Safety PIVCs are used to reduce the risk of needle injuries. Adopting safety IV catheters lowered sharp injuries by 63% during 2001-2004, according to the Exposure Prevention Information Network (EPINet). Its implementation has become a priority in most healthcare facilities in the US, notably since the Needlestick Safety and Prevention Act mandated the usage of safety devices in 2000. Earlier, anesthesiologists resisted the use of safe IV catheters for various reasons. Several anesthesiologists expressed their concern regarding safer equipment that may compromise patient safety. However, with the growing advancements in safety PIVCs, anesthesiologists are constantly adopting IV catheters for hospitalized patients.

End-User Insights

The global market is segmented into hospitals, ambulatory surgical centers, home care, and others. The hospital segment owns the highest PIVC market share and is estimated to exhibit a CAGR of 0.64% during the forecast period. Every hospital uses PIVCs to withdraw blood and fluid samples and administer drugs and nutrients. In emergency care and intensive care units, blood collection through IV lines is very popular owing to the high efficiency associated with the dual use of single venous access for the infusion of medications and the collection of multiple blood specimens for diagnosis and treatment purposes.

In ambulatory care, several surgeries are performed on the same day in outpatient surgery centers that provide advanced healthcare facilities to patients. ASCs have many benefits, making patients prefer them over hospitals. These include reduced cost, low risk of infection, clinical excellence, easy navigation, and better patient care than in other medical settings. ASC focuses on a specialized number of surgical procedures, adding quality, and is patient-centric and cost-effective. Patients can save as much as 50% in out-of-pocket expenses by choosing an ASC over a hospital. The significant advantage of ASC is that it provides surgical and therapeutic services that do not require extended periods of hospitalization.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global peripheral intravenous catheters (PIVC) market shareholder and is anticipated to boost at a CAGR of 0.42% during the forecast period. Due to population growth, there has been a growing rate of infectious and chronic illnesses such as heart diseases, cancer, and others, which is increasing the need for PIVCs in the region. This is further contributing to the rising hospitalization rates, increasing number of surgical procedures, growing need for supplying drugs and nutrients for patients intravenously, and rising injectable drugs market demand compared to oral drugs. North America has advanced hospital infrastructure that focuses on avoiding risks of infection and cross-contamination by opting for PIVCs such as closed/integrated IV and midline catheters. As there is high awareness regarding PIVCs and their associated complications, the adoption of safety PIVCs is increasing rapidly in the region.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe's Peripheral Intravenous Catheters (pivc) Market Trend

Europe is estimated to exhibit a CAGR of 1.27% over the forecast period. Chronic disease-related aging and its prevalence have dramatically increased in the region. Further, due to various risk factors such as smoking, pollution, and other underlying diseases, the prevalence of chronic diseases among both adults and the elderly population has increased. The highly advanced healthcare system and an increasing number of vendors offering various PIVCs are further boosting the market growth in the region. In addition, the healthcare system in Europe is highly advanced, regulated, sophisticated, and evolved with a standard reimbursement structure. A rise in chronic diseases has contributed to the peripheral intravenous catheters market. Further, the rising demand for retractable and safety needles is propelling the growth of PIVCs in the European region. The presence of highly trained medical professionals has further positively impacted the usage of PIVCs for treating patients by supplying them with drugs and nutrition.

Asia-Pacific Peripheral Intravenous Catheters (pivc) Market Trend

Asia-Pacific is the fastest-growing region in the PIVCs market. Significant factors contributing to the market's growth across the region include the rising elderly population suffering from acute and chronic conditions. Most deaths in the Asia-Pacific occur due to non-communicable diseases, especially in the Western Pacific and Southeast Asia. Improvement in healthcare access and favorable government initiatives have increased patient admissions in various healthcare centers and the simultaneous peripheral intravenous catheters market demand. In addition, the incidence rate of various lifestyle diseases, including diabetes, is highly prevalent in Asian countries. For instance, in 2017, around 80 million people had diabetes in Southeast Asia, which is anticipated to reach approximately 151 million by 2045. Further, the Asia-Pacific region has the highest number of obese people globally, accounting for around one billion overweight and obese adults. Due to the disease burden and high-risk factors, the region is desirable for many global and local vendors manufacturing PIVCs.

LAMEA accounted for a minimal peripheral intravenous catheter market share in 2022. Though these regions account for a smaller revenue share, they have many people associated with chronic diseases and need advanced healthcare infrastructure. Growing awareness of advanced PIVCs will boost the demand for PIVCs during the forecast period. In addition, the presence of a few established vendors in these regions is one of the primary reasons for the low market share.

List of Key and Emerging Players in Peripheral Intravenous Catheters (PIVC) Market